Literature DB >> 8355030

CD44 expression in human astrocytes and oligodendrocytes in culture.

G Moretto1, R Y Xu, S U Kim.   

Abstract

CD44 is a glycoprotein present on the surface of some lymphocyte cell populations and other non-lymphoid cells, and is involved in many functions related to cell-cell and cell-matrix interactions. In this study, expression of CD44 antigen in primary neural cell cultures derived from fetal and adult human brains was investigated. In cultures processed for double immunofluorescence staining, approximately 80% of fetal astrocytes and more than 95% of adult astrocytes expressed the CD44 antigen on the cell bodies and processes; CD44 was also detected in 50-60% of adult oligodendrocytes. Neurons in fetal brain cell cultures did not express CD44 at all. Western blot analysis performed in astrocyte- and in neuron-enriched cultures confirmed the results from immunostaining and showed that the antibody against CD44 reacted with a polypeptide, of approximately 80 kD, that is present exclusively in the astrocyte-enriched cultures, but absent in neuron-enriched cultures. Our results indicate that CD44 glycoprotein is constitutively expressed in the human cells of glial cell lineage and its role is likely to be associated with normal neuroglia-mediated adhesion/recognition processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355030     DOI: 10.1097/00005072-199307000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

Review 1.  Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system.

Authors:  G H Baltuch; N de Tribolet; E G Van Meir
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

2.  CD44-positive cells are candidates for astrocyte precursor cells in developing mouse cerebellum.

Authors:  Na Cai; Masashi Kurachi; Koji Shibasaki; Takayuki Okano-Uchida; Yasuki Ishizaki
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

3.  Temporal Changes in Transcription Factor Expression Associated with the Differentiation State of Cerebellar Neural Stem/Progenitor Cells During Development.

Authors:  Masae Naruse; Koji Shibasaki; Yasuki Ishizaki
Journal:  Neurochem Res       Date:  2017-10-07       Impact factor: 3.996

4.  CD44 expression in the developing human retina.

Authors:  S Nishina; A Hirakata; T Hida; H Sawa; N Azuma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

5.  CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma.

Authors:  S Gunia; S Hussein; D L Radu; K M Pütz; R Breyer; H Hecker; M Samii; G F Walter; A C Stan
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

6.  CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis.

Authors:  Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2011-05-06       Impact factor: 5.422

7.  Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

Authors:  S K Singhrao; J W Neal; N K Rushmere; B P Morgan; P Gasque
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

8.  Expression of variant CD44 epitopes in human astrocytic brain tumors.

Authors:  R H Eibl; T Pietsch; J Moll; P Skroch-Angel; K H Heider; K von Ammon; O D Wiestler; H Ponta; P Kleihues; P Herrlich
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

9.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

10.  CD44H is expressed by cells of the oligodendrocyte lineage and by oligodendrogliomas in humans.

Authors:  Corinne Bouvier-Labit; Agnès Liprandi; Gilberte Monti; Jean François Pellissier; Dominique Figarella-Branger
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.